Therapeutic Controversies in the Rheumatic DiseasesRobert F. Willkens, Stephen L. Dahl |
Contents
Analgesic Agents That Act Centrally to Modify | 9 |
Clinical | 27 |
4A The Use of Steroidal Agents in the Oral Route | 71 |
Copyright | |
12 other sections not shown
Common terms and phrases
Acad Sci activity acute administration adverse reactions agents allopurinol analgesic Ann Intern Ann NY Acad Ann Rheum antibody antigen antimalarials Arthritis Rheum aspirin associated auranofin autoimmune azathioprine cartilage cells chloroquine chronic chrysotherapy Clin clinical controlled corticosteroids cyclophosphamide cyclosporine cytotoxic daily dose decreased dimethyl sulfoxide DMSO double-blind efficacy Engl enzymes excretion function gastrointestinal glucocorticoids gold hepatic high-dose hydroxychloroquine hyperuricemia ibuprofen immune immunosuppressive improvement indomethacin inflammation inflammatory inhibition joint Lancet lupus nephritis lymphocyte metabolism methotrexate methylprednisolone months nonsteroidal anti-inflammatory drugs NSAIDs occur oral orgotein osteoarthritis pain parenteral patients receiving patients treated patients with rheumatoid penicillamine Pharmacol phenylbutazone placebo plasma prednisone prostaglandin proteinuria pulse steroid pulse therapy reduced regimens remission renal reported response Rheum rheumatic diseases rheumatoid arthritis Rheumatol salicylate serum side effects sodium steroids sulindac suppl syndrome systemic lupus erythematosus therapeutic tion toxicity treatment of rheumatoid trial ulcer urate uric acid uricosuric vitro weeks